Male Hypogonadism Global Clinical Trials Review H1 2015


#308801

96pages

GlobalData

$ 2500

In Stock

Male Hypogonadism Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, Male Hypogonadism Global Clinical Trials Review, H1, 2015" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Male Hypogonadism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Male Hypogonadism 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Male Hypogonadism Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Male Hypogonadism 33
Jun 15, 2015: Lipocine Announces Successful Completion of Food Effect Study for LPCN 1021, an Oral Testosterone Product Candidate 33
Jun 01, 2015: Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial for Fispemifene in Men With Symptomatic Secondary Hypogonadism 33
May 11, 2015: Lipocine Announces Presentation of Additional LPCN 1021 Clinical Data at American Urological Association Annual Meeting 34
Apr 30, 2015: Lipocine Announces Completion of LPCN 1021, Oral Testosterone, Phase 3 Clinical Trial 34
Apr 10, 2015: Lipocine Announces Presentation of Additional LPCN 1021 Clinical Data at American Society of Andrology 40th Annual Conference 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Repros Therapeutics Inc. 35
Clinical Trial Overview of Repros Therapeutics Inc. 35
Abbott Laboratories 37
Clinical Trial Overview of Abbott Laboratories 37
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Endo International Plc 41
Clinical Trial Overview of Endo International Plc 41
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
Merck & Co., Inc. 43
Clinical Trial Overview of Merck & Co., Inc. 43
Ferring International Center S.A. 44
Clinical Trial Overview of Ferring International Center S.A. 44
GlaxoSmithKline Plc 45
Clinical Trial Overview of GlaxoSmithKline Plc 45
Clarus Therapeutics, Inc. 46
Clinical Trial Overview of Clarus Therapeutics, Inc. 46
Antares Pharma, Inc. 47
Clinical Trial Overview of Antares Pharma, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Gulhane School of Medicine 48
Clinical Trial Overview of Gulhane School of Medicine 48
Massachusetts General Hospital 49
Clinical Trial Overview of Massachusetts General Hospital 49
U.S. Department of Veterans Affairs 50
Clinical Trial Overview of U.S. Department of Veterans Affairs 50
University of Washington 51
Clinical Trial Overview of University of Washington 51
Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
Odense University Hospital 53
Clinical Trial Overview of Odense University Hospital 53
Rijnstate Hospital 54
Clinical Trial Overview of Rijnstate Hospital 54
Barnsley Hospital NHS Foundation Trust 55
Clinical Trial Overview of Barnsley Hospital NHS Foundation Trust 55
Boston University 56
Clinical Trial Overview of Boston University 56
National Institute on Aging 57
Clinical Trial Overview of National Institute on Aging 57
Five Key Clinical Profiles 58
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 96

List of Tables
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region, 2015* 7
Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2015* 15
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2015* 18
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Male Hypogonadism Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Male Hypogonadism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Male Hypogonadism Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Repros Therapeutics Inc., 2015* 35
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 37
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International Plc, 2015* 41
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 42
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 43
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 44
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 45
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Clarus Therapeutics, Inc., 2015* 46
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Antares Pharma, Inc., 2015* 47
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Gulhane School of Medicine, 2015* 48
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 49
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 50
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 51
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 52
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2015* 53
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rijnstate Hospital, 2015* 54
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnsley Hospital NHS Foundation Trust, 2015* 55
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2015* 56
Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2015* 57

List of Figures
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2015* 15
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2015* 18
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 94